Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001274173-25-000125·Janus Henderson Group Ltd.
Schedule 13G ownership disclosure
TRAVERE THERAPEUTICS INC
Common Stock · CUSIP: 89422G107
Event date: 2025-03-31
- Filing-level shares
- 7,566,963
- Percent of class
- 8.5%
- JANUS HENDERSON GROUP PLC
Shares: 7,566,963 · Class: 8.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000125
- Form type
- SCHEDULE 13G
- Filer
- Janus Henderson Group Ltd.
- CIK
- CIK 1274173
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership